Cite

HARVARD Citation

    Dragun, D. et al. (n.d.). Significant Anti-CMV/BKV Effect of a Modern Everolimus-Based Regimen Comparted to Standard Tacrolimus-MPA Regimen in de Novo Kidney Transplant Recipients. Transplantation. p. . [Online]. 
  
Back to record